Global analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNFα expression

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Müller, Mario M ^a,d   Lehmann, Roland ^a   Klassert, Tilman E ^a   Reifenstein, Stella ^a   Conrad, Theresia ^a,c   Moore, Christoph ^a   Kuhn, Anna ^a,c   Behnert, Andrea ^d   Guthke, Reinhard ^c   Driesch, Dominik ^b   Slevogt, Hortense ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b BIOCONTROL JENA GMBH   (Germany)

^c HANS KNÖLL INSTITUTE   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; DECANOIC ACID; DECANOIC ACID DERIVATIVE; GLYCOPROTEIN; GPR84 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEOME; TUMOR NECROSIS FACTOR;

CELL CULTURE; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MONOCYTE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELLS, CULTURED; DECANOIC ACIDS; GLYCOPROTEINS; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; PROTEOME; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85018755038     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00828-y     Document Type: Article

References (70)

1. Dube, D. H., Bertozzi, C. R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nature reviews. Drug discovery 4, 477-488, doi:10.1038/nrd1751 (2005).
2. Hopkins, A. L., Groom, C. R. The druggable genome. Nature reviews. Drug discovery 1, 727-730, doi:10.1038/nrd892 (2002).
3. Josic, D., Clifton, J. G. Mammalian plasma membrane proteomics. Proteomics 7, 3010-3029, doi:10.1002/pmic.200700139 (2007).
4. Macher, B. A., Yen, T. Y. Proteins at membrane surfaces-a review of approaches. Molecular bioSystems 3, 705-713, doi:10.1039/b708581h (2007).
5. Cao, L., Clifton, J. G., Reutter, W., Josic, D. Mass spectrometry-based analysis of rat liver and hepatocellular carcinoma Morris hepatoma 7777 plasma membrane proteome. Analytical chemistry 85, 8112-8120, doi:10.1021/ac400774g (2013).
6. Rybak, J. N., et al. In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nature methods 2, 291-298, doi:10.1038/nmeth745 (2005).
7. Autelitano, F., et al. Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomics. PloS one 9, e110316, doi:10.1371/journal.pone.0110316 (2014).
8. Hang, H. C., Yu, C., Kato, D. L., Bertozzi, C. R. A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proceedings of the National Academy of Sciences of the United States of America 100, 14846-14851, doi:10.1073/pnas.2335201100 (2003).
9. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nature biotechnology 21, 660-666, doi:10.1038/nbt827 (2003).
10. Zielinska, D. F., Gnad, F., Wisniewski, J. R., Mann, M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141, 897-907, doi:10.1016/j.cell.2010.04.012 (2010).
11. Xiong, L., Andrews, D., Regnier, F. Comparative proteomics of glycoproteins based on lectin selection and isotope coding. Journal of proteome research 2, 618-625, doi:10.1021/pr0340274 (2003).
12. Cao, J., et al. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach. Journal of proteome research 8, 662-672, doi:10.1021/pr800826u (2009).
13. Wu, J., Xie, X., Nie, S., Buckanovich, R. J., Lubman, D. M. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis. Journal of proteome research 12, 3342-3352, doi:10.1021/pr400169n (2013).
14. Boheler, K. R., et al. A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, drug targets. Stem cell reports 3, 185-203, doi:10.1016/j.stemcr.2014.05.002 (2014).
15. Yen, T. Y., Macher, B. A., McDonald, C. A., Alleyne-Chin, C., Timpe, L. C. Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/benign versus malignant cell lines and basal versus luminal cell lines. Journal of proteome research 11, 656-667, doi:10.1021/pr201041j (2012).
16. Deeb, S. J., Cox, J., Schmidt-Supprian, M., Mann, M. N-linked glycosylation enrichment for in-depth cell surface proteomics of diffuse large B-cell lymphoma subtypes. Molecular & cellular proteomics: MCP 13, 240-251, doi:10.1074/mcp.M113.033977 (2014).
17. Bausch-Fluck, D., et al. A mass spectrometric-derived cell surface protein atlas. PloS one 10, e0121314, doi:10.1371/journal. pone.0121314 (2015).
18. Biswas, S. K., Lopez-Collazo, E. Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends in immunology 30, 475-487, doi:10.1016/j.it.2009.07.009 (2009).
19. Cavaillon, J. M., Adib-Conquy, M. Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Critical care (London, England) 10, 233, doi:10.1186/cc5055 (2006).
20. del Fresno, C., et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: Demonstration in isolated monocytes from cystic fibrosis patients. Journal of immunology (Baltimore, Md.: 1950) 182, 6494-6507, doi:10.4049/jimmunol.0803350 (2009).
21. del Fresno, C., et al. Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes. Journal of endotoxin research 13, 39-52, doi:10.1177/0968051907078623 (2007).
22. Woollard, K. J., Geissmann, F. Monocytes in atherosclerosis: Subsets and functions. Nature reviews. Cardiology 7, 77-86, doi:10.1038/nrcardio.2009.228 (2010).
23. Shalova, I. N., et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1alpha. Immunity 42, 484-498, doi:10.1016/j.immuni.2015.02.001 (2015).
24. Hotchkiss, R. S., Monneret, G., Payen, D. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nature reviews. Immunology 13, 862-874, doi:10.1038/nri3552 (2013).
25. Poehlmann, H., Schefold, J. C., Zuckermann-Becker, H., Volk, H. D., Meisel, C. Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: A prospective observational analysis. Critical care (London, England) 13, R119, doi:10.1186/cc7969 (2009).
26. del Fresno, C., et al. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: Down-regulation of TREM-1 as putative underlying mechanism. PloS one 3, e2667, doi:10.1371/journal.pone.0002667 (2008).
27. Lopez-Collazo, E., del Fresno, C. Pathophysiology of endotoxin tolerance: Mechanisms and clinical consequences. Critical care (London, England) 17, 242, doi:10.1186/cc13110 (2013).
28. Soares-Schanoski, A., et al. Impaired antigen presentation and potent phagocytic activity identifying tumor-tolerant human monocytes. Biochemical and biophysical research communications 423, 331-337, doi:10.1016/j.bbrc.2012.05.124 (2012).
29. Medzhitov, R., Horng, T. Transcriptional control of the inflammatory response. Nature reviews. Immunology 9, 692-703, doi:10.1038/nri2634 (2009).
30. Xiong, Y., Medvedev, A. E. Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, A20. Journal of leukocyte biology 90, 1141-1148, doi:10.1189/jlb.0611273 (2011).
31. Wolk, K., Docke, W. D., von Baehr, V., Volk, H. D., Sabat, R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96, 218-223 (2000).
32. Singh, A. K., et al. Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window. Infection and immunity 83, 1853-1868, doi:10.1128/iai.02833-14 (2015).
33. Kaakoush, N. O., et al. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus. Infection and immunity 83, 832-845, doi:10.1128/iai.03012-14 (2015).
34. Kuo, C. C., Kuo, C. W., Liang, C. M., Liang, S. M. A transcriptomic and proteomic analysis of the effect of CpG-ODN on human THP-1 monocytic leukemia cells. Proteomics 5, 894-906, doi:10.1002/pmic.200401144 (2005).
35. Huang, J., Kast, J. Quantitative Glycoproteomic Analysis Identifies Platelet-Induced Increase of Monocyte Adhesion via the Up-Regulation of Very Late Antigen 5. Journal of proteome research 14, 3015-3026, doi:10.1021/acs.jproteome.5b00407 (2015).
36. Klassert, T. E., et al. Modulatory role of vitamin A on the Candida albicans-induced immune response in human monocytes. Medical microbiology and immunology 203, 415-424, doi:10.1007/s00430-014-0351-4 (2014).
37. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acids research 29, e45-45, doi:10.1093/nar/29.9.e45 (2001).
38. Pfaffl, M. W., Tichopad, A., Prgomet, C., Neuvians, T. P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnology letters 26, 509-515, doi:10.1023/B:BILE.0000019559.84305.47 (2004).
39. Cox, J., Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nature biotechnology 26, 1367-1372, doi:10.1038/nbt.1511 (2008).
40. Cox, J., et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Molecular & cellular proteomics: MCP 13, 2513-2526, doi:10.1074/mcp.M113.031591 (2014).
41. Tyanova, S., et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nature methods 13, 731-740, doi:10.1038/nmeth.3901 (2016).
42. Vizcaino, J. A., et al. 2016 update of the PRIDE database and its related tools. Nucleic acids research 44, D447-456, doi:10.1093/nar/gkv1145 (2016).
43. Krogh, A., Larsson, B., von Heijne, G., Sonnhammer, E. L. Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. Journal of molecular biology 305, 567-580, doi:10.1006/jmbi.2000.4315 (2001).
44. Huang da, W., Sherman, B. T., Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4, 44-57, doi:10.1038/nprot.2008.211 (2009).
45. Fernando, L. P., Fernando, A. N., Ferlito, M., Halushka, P. V., Cook, J. A. Suppression of Cox-2 and TNF-alpha mRNA in endotoxin tolerance: Effect of cycloheximide, antinomycin D, okadaic acid. Shock (Augusta, Ga.) 14, 128-133, doi:10.1097/00024382-200014020-00009 (2000).
46. Jacinto, R., Hartung, T., McCall, C., Li, L. Lipopolysaccharide-A nd lipoteichoic acid-induced tolerance and cross-tolerance: Distinct alterations in IL-1 receptor-associated kinase. Journal of immunology (Baltimore, Md.: 1950) 168, 6136-6141, doi:10.4049/jimmunol.168.12.6136 (2002).
47. Peck, O. M., et al. Differential regulation of cytokine and chemokine production in lipopolysaccharide-induced tolerance and priming. Cytokine 26, 202-208, doi:10.1016/j.cyto.2004.02.011 (2004).
48. Steinberger, P., et al. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. Journal of immunology (Baltimore, Md.: 1950) 172, 2352-2359, doi:10.4049/jimmunol.172.4.2352 (2004).
49. Huang, G., Wen, Q., Zhao, Y., Gao, Q., Bai, Y. NF-kappaB plays a key role in inducing CD274 expression in human monocytes after lipopolysaccharide treatment. PloS one 8, e61602, doi:10.1371/journal.pone.0061602 (2013).
50. Wissink, S., van de Stolpe, A., Caldenhoven, E., Koenderman, L., van der Saag, P. T. NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Immunobiology 198, 50-64, doi:10.1016/S0171-2985(97)80026-5 (1997).
51. Lagana, A., et al. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Molecular and cellular biology 26, 3181-3193, doi:10.1128/mcb.26.8.3181-3193.2006 (2006).
52. Wang, J., Wu, X., Simonavicius, N., Tian, H., Ling, L. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. The Journal of biological chemistry 281, 34457-34464, doi:10.1074/jbc.M608019200 (2006).
53. Suzuki, M., et al. Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. The Journal of biological chemistry 288, 10684-10691, doi:10.1074/jbc.M112.420042 (2013).
54. Foster, S. L., Medzhitov, R. Gene-specific control of the TLR-induced inflammatory response. Clinical immunology (Orlando, Fla.) 130, 7-15, doi:10.1016/j.clim.2008.08.015 (2009).
55. Slevogt, H., et al. CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nature. immunology 9, 1270-1278, doi:10.1038/ni.1661 (2008).
56. Brint, E. K., et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nature immunology 5, 373-379, doi:10.1038/ni1050 (2004).
57. Wald, D., et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nature immunology 4, 920-927, doi:10.1038/ni968 (2003).
58. Allam, J. P., et al. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. The Journal of allergy and clinical immunology 121, 368-374.e361, doi:10.1016/j.jaci.2007.09.045 (2008).
59. Monneret, G., et al. The anti-inflammatory response dominates after septic shock: Association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunology letters 95, 193-198, doi:10.1016/j.imlet.2004.07.009 (2004).
60. Monneret, G., Venet, F. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy. Cytometry. Part B, Clinical cytometry 90, 376-386, doi:10.1002/cyto.b.21270 (2016).
61. de Saint-Vis, B., et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9, 325-336, doi:10.1016/S1074-7613(00)80615-9 (1998).
62. Barois, N., de Saint-Vis, B., Lebecque, S., Geuze, H. J., Kleijmeer, M. J. MHC class II compartments in human dendritic cells undergo profound structural changes upon act ivation. Traff ic (Copenhagen, Denmark) 3, 894-905, doi:10.1034/j.1600-0854.2002.31205.x (2002).
63. Larabee, J. L., Shakir, S. M., Barua, S., Ballard, J. D. Increased cAMP in monocytes augments Notch signaling mechanisms by elevating RBP-J and transducin-like enhancer of Split (TLE). The Journal of biological chemistry 288, 21526-21536, doi:10.1074/jbc. M113.465120 (2013).
64. Piliponsky, A. M., et al. Thymic Stromal Lymphopoietin Improves Survival and Reduces Inflammation in Sepsis. American journal of respiratory cell and molecular biology 55, 264-274, doi:10.1165/rcmb.2015-0380OC (2016).
65. Unsinger, J., et al. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. The Journal of infectious diseases 206, 606-616, doi:10.1093/infdis/jis383 (2012).
66. Shindo, Y., et al. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia. Journal of leukocyte biology 101, 543-554, doi:10.1189/jlb.4A1215-581R (2017).
67. Aluwihare, P., et al. Mice that lack activity of alphavbeta6-A nd alphavbeta8-integrins reproduce the abnormalities of Tgfb1-A nd Tgfb3-null mice. Journal of cell science 122, 227-232, doi:10.1242/jcs.035246 (2009).
68. Henderson, N. C., et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nature medicine 19, 1617-1624, doi:10.1038/nm.3282 (2013).
69. Nagasaki, H., et al. Inflammatory changes in adipose tissue enhance expression of GPR84, a medium-chain fatty acid receptor: TNFalpha enhances GPR84 expression in adipocytes. FEBS letters 586, 368-372, doi:10.1016/j.febslet.2012.01.001 (2012).
70. Abdel-Aziz, H., et al. GPR84 and TREM-1 signaling contribute to the pathogenesis of reflux esophagitis. Molecular medicine (Cambridge, Mass.) 21, 1, doi:10.2119/molmed.2015.00098 (2015).